The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Open accessAbstract
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low yields. Here we report a cellular-nanoporation method for the production of large quantities of exosomes containing therapeutic mRNAs and targeting peptides. We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and transient electrical stimulus that promotes the release of exosomes carrying transcribed mRNAs and targeting peptides. Compared with bulk electroporation and other exosome-production strategies, cellular nanoporation produced up to 50-fold more exosomes and a more than 10 3-fold increase in exosomal mRNA transcripts, even from cells with low basal levels of exosome secretion. In orthotopic phosphatase and tensin homologue (PTEN)-deficient glioma mouse models, mRNA-containing exosomes restored tumour-suppressor function, enhanced inhibition of tumour growth and increased survival. Cellular nanoporation may enable the use of exosomes as a universal nucleic-acid carrier for applications requiring transcriptional manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“The CNP technology increases the exosome yield and the mRNA amount within the exosomes [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In addition, this strategy increased mRNA loading in exosomes by 100-fold compared to conventional electroporation methods.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Compared to exosomes produced endogenously without involving external stimuli, CNP-treated exosomes from cells of the same origin have an increased mRNA encapsulation efficiency of 3–4 folds.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“By modifying the exosome CD47 with these peptides, the targeting ability was improved.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Chemical modification of exosomes was carried out to target GL261 gliomas and U87 glioblastomas.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Moreover, when PTEN mRNA was additionally modified with the CDX peptide, the resulting exosomes exhibited a twofold increase in accumulation in mouse U87 gliomas, leading to prolonged survival.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Similarly, modification of PTEN mRNA with CREKA peptide resulted in a 1.5-fold increase in accumulation in mouse U87 gliomas and improved survival [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Yang et al. modified CD47-derived exosomes by incorporating a glioma targeting peptide at the N terminus. This modification allowed for selective uptake of tumor suppression gene, phosphatase and tensin homolog (PTEN) cargo by glioma cells. As a result, the proliferation of tumor cells was effectively inhibited [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In Yang et al. research, mouse embryonic fibroblast-derived exosomes were able to deliver PTEN (phosphatase and homologous tensin) mRNA to inhibit mouse glioma growth [49].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [49]
In the citing paper
“Naturally derived membrane lipids (for example, exosomes and cell membranes) can also be applied for mRNA delivery116,249,250.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [249]
In the citing paper
“However, large-scale production and purification of natural exosomes present significant challenges. Standardization of isolation techniques remains an area of ongoing research, with variations in yield and purity across different methods [36].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,763
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,329
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citation
Cited by
Sorted by citations
Items 101–200 of 744
Clinical relevance of extracellular vesicles in cancer — therapeutic and diagnostic potential
Greening, D. W., Xu, R., Rai, A., Suwakulsiri, W., Chen, M., & Simpson, R. J. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01074-2 · Cited by 129
Binzel, D. W., Li, X., Burns, N., Khan, E., Lee, W.-J., Chen, L.-C., Ellipilli, S., Miles, W. O., Ho, Y. S., & Guo, P. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00009 · Cited by 97
Wang, Z., Mo, H., He, Z., Chen, A., & Cheng, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113480 · Cited by 100
Zhang, C., Ma, Y., Zhang, J., Kuo, J. C., Zhang, Z., Xie, H., Zhu, J., & Liu, T. (2022) · Molecules · doi:10.3390/molecules27061943 · Cited by 95
Self-citationSong, H., Chen, X., Hao, Y., Wang, J., Xie, Q., & Wang, X. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01638-9 · Cited by 98
Self-citationExosome-Based Carrier for RNA Delivery: Progress and Challenges
Lu, Y., Huang, W. C., Li, M., & Zheng, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020598 · Cited by 103
The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs
Nicze, M., Borówka, M., Dec, A., Niemiec, A., Bułdak, Ł., & Okopień, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020815 · Cited by 100
Yang, Z., Yang, Y., Xu, Y., Jiang, W., Shao, Y., Xing, J., Chen, Y., & Han, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02528-x · Cited by 95
Self-citationRecent advances in scalable exosome production: Challenges and innovations
Chen, H., & Li, Q. (2025) · Chinese Journal of Plastic and Reconstructive Surgery · doi:10.1016/j.cjprs.2025.05.001 · Cited by 102
Engineering nanoparticle toolkits for mRNA delivery
Sun, B., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 96
Self-citationThe application of exosomes and Exosome-nanoparticle in treating brain disorders
Salarpour, S., Barani, M., Pardakhty, A., Khatami, M., & Chauhan, N. P. S. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.118549 · Cited by 92
Chen, L., Qu, J., Mei, Q., Chen, X., Fang, Y., Chen, L., Li, Y., & Xiang, C. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02511-6 · Cited by 93
Pan, Y., Wu, W., Jiang, X., & Liu, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114817 · Cited by 101
Li, X., Qi, J., Wang, J., Hu, W., Zhou, W., Wang, Y., & Li, T. (2024) · Theranostics · doi:10.7150/thno.84291 · Cited by 100
Self-citationEngineered extracellular vesicles for tissue repair and regeneration
Zhang, Y., Wu, D., Chen, Z., Bai, M., Wan, Y., Zheng, Q. C., Fan, Z., Wang, X., & Yang, C. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae062 · Cited by 90
Self-citationLipid-Based Nanovesicular Drug Delivery Systems
Limongi, T., Susa, F., Marini, M., Allione, M., Torre, B., Pisano, R., & Fabrizio, E. M. D. (2021) · Nanomaterials · doi:10.3390/nano11123391 · Cited by 90
Tiwari, P., Yadav, K., Shukla, R. P., Gautam, S., Marwaha, D., Sharma, M., & Mishra, P. R. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.016 · Cited by 88
Bone-Targeted Extracellular Vesicles from Mesenchymal Stem Cells for Osteoporosis Therapy
Wang, Y., Yao, J., Cai, L., Liu, T., Wang, X., Zhang, Y., Zhou, Z., Li, T., Liu, M., Lai, R., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s263756 · Cited by 85
Self-citationApplication of engineered extracellular vesicles for targeted tumor therapy
Zhang, F., Guo, J. J., Zhang, Z., Duan, M., Wang, G., Qian, Y., Zhao, H., Yang, Z., & Jiang, X. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00798-y · Cited by 92
Self-citationStrategies for Engineering of Extracellular Vesicles
Aleksandrovna, D. A., Emene, C. C., Barlev, N. A., & Gomzikova, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713247 · Cited by 91
Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
Duan, L., Ouyang, K., Wang, J., Xu, L., Xu, X., Wen, C., Xie, Y., Liang, Y., & Xia, J. (2021) · ChemBioChem · doi:10.1002/cbic.202100359 · Cited by 82
Paloncýová, M., Čechová, P., Šrejber, M., Kührová, P., & Otyepka, M. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c03109 · Cited by 82
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 85
Self-citationCRISPR-Cas9 delivery strategies with engineered extracellular vesicles
Lu, Y., Godbout, K., Lamothe, G., & Tremblay, J. P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102040 · Cited by 90
The exosome: a review of current therapeutic roles and capabilities in human reproduction
Dimik, M., Abeysinghe, P., Logan, J., & Mitchell, M. D. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01225-3 · Cited by 86
Engineering approaches for effective therapeutic applications based on extracellular vesicles
Kwon, S., Shin, S., Do, M., Oh, B. H., Song, Y., Bui, V. D., Lee, E. S., Jo, D., Cho, Y. W., Kim, D., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.062 · Cited by 79
Multiplexed strategies toward clinical translation of extracellular vesicles
Song, J., Song, B., Yuan, L., & Yang, G. (2022) · Theranostics · doi:10.7150/thno.75899 · Cited by 81
Extracellular Vesicles: An Emerging Nanoplatform for Cancer Therapy
Ma, Y., Dong, S., Li, X., Kim, B. Y. S., Yang, Z., & Jiang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.606906 · Cited by 73
Self-citationAdvances in Nanoparticles for Effective Delivery of RNA Therapeutics
Byun, M. J., Lim, J., Kim, S.-N., Park, D.-H., Kim, T. P., Park, W., & Park, C. G. (2022) · BioChip Journal · doi:10.1007/s13206-022-00052-5 · Cited by 78
Tian, F., Liu, C., Deng, J., & Sun, J. (2022) · Accounts of Materials Research · doi:10.1021/accountsmr.1c00276 · Cited by 76
Self-citation80 years of extracellular vesicles: from discovery to clinical translation
Li, Q., Ding, Y., Shi, Y., Qiu, C., Lei, L., Li, S., Zhu, Z., Zheng, J., Qin, C., Wang, K., et al. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.161 · Cited by 81
Self-citationStrategies to Enhance Extracellular Vesicle Production
Hahm, J., Kim, J., & Park, J. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00364-x · Cited by 79
mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
Chabanovska, O., Galow, A.-M., David, R., & Lemcke, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114002 · Cited by 81
Kim, H., Kim, D. E., Han, G., Lim, N. R., Kim, E. H., Jang, Y., Cho, H., Jang, H., Kim, K. H., Kim, S. H., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202102027 · Cited by 73
Extracellular vesicle‐based nucleic acid delivery
Lu, M., Shao, W., Xing, H., & Huang, Y. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20220007 · Cited by 75
Wu, H., Zhang, T., Li, N., & Gao, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.023 · Cited by 73
Exosomes in cancer nanomedicine: biotechnological advancements and innovations
Liu, J. J. J., Liu, D., To, S. K. Y., & Wong, A. S. T. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02372-0 · Cited by 89
The role and therapeutic potential of MSC-derived exosomes in osteoarthritis
Bao, C., & He, C. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109002 · Cited by 73
Lenzini, S. B., Debnath, K., Joshi, J. C., Wong, S. W., Srivastava, K., Geng, X. H., Cho, I. S., Song, A., Bargi, R., Lee, J. C., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c03231 · Cited by 72
Hazrati, A., Malekpour, K., Soudi, S., & Hashemi, S. M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113943 · Cited by 73
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Li, D., Liu, Q., Yang, M., Xu, H., Zhu, M., Zhang, Y., Xu, J., Tian, C., Yao, J., Wang, L., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10492 · Cited by 74
Current Nanoparticle-Based Technologies for Osteoarthritis Therapy
Jin, G.-Z. (2020) · Nanomaterials · doi:10.3390/nano10122368 · Cited by 64
Converting extracellular vesicles into nanomedicine: loading and unloading of cargo
Joshi, B. S., Ortíz-Rios, D., & Zuhorn, I. S. (2021) · Materials Today Nano · doi:10.1016/j.mtnano.2021.100148 · Cited by 71
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Ouranidis, A., Vavilis, T., Mandala, E., Davidopoulou, C., Stamoula, Ε., Markopoulou, C. K., Karagianni, A., & Kachrimanis, K. (2021) · Biomedicines · doi:10.3390/biomedicines10010050 · Cited by 75
Extracellular vesicles for the delivery of gene therapy
Ianni, E. D., Obuchi, W., Breyne, K., & Breakefield, X. O. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00277-7 · Cited by 83
Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment
Xu, Y., Feng, K., Zhao, H., Di, L., Wang, L., & Wang, R. (2022) · Theranostics · doi:10.7150/thno.67775 · Cited by 70
Qian, K., Fu, W., Li, T., Zhao, J., Lei, C., & Hu, S. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02492-1 · Cited by 72
Lopes, D., Lopes, J., Pereira-Silva, M., Peixoto, D., Rabiee, N., Veiga, F., Moradi, O., Guo, Z.-H., Wang, X.-D., Conde, J., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00453-z · Cited by 36
Self-citationRecent advances of smart materials for ocular drug delivery
Wang, X., Luan, F., Yue, H., Song, C., Wang, S., Feng, J., Zhang, X., Yang, W. H., Li, Y., Wei, W., et al. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115006 · Cited by 70
Self-citationDave, K. M., Pinky, P. P., & Manickam, D. S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114068 · Cited by 80
Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Ubanako, P., Mirza, S., Ruff, P., & Penny, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1447953 · Cited by 68
Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages
Guo, W., Li, Y., Pang, W., & Shen, H. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.003 · Cited by 68
Production and Utility of Extracellular Vesicles with 3D Culture Methods
Ester, M. C., & Day, R. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020663 · Cited by 69
Standardization Approaches for Extracellular Vesicle Loading with Oligonucleotides and Biologics
Roerig, J., & Schulz‐Siegmund, M. (2023) · Small · doi:10.1002/smll.202301763 · Cited by 67
Huang, C., Liu, Z., Chen, M., Du, L., Liu, C., Wang, S., Zheng, Y., & Liu, W. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01182-y · Cited by 67
Pan, W., Chen, H., Wang, A., Wang, F., & Zhang, X. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121524 · Cited by 69
Current Strategies for Promoting the Large-scale Production of Exosomes
Qu, Q., Fu, B., Long, Y., Liu, Z., & Tian, X. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230216095938 · Cited by 68
Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer
Chiang, C.-L., Ma, Y., Hou, Y.-C., Pan, J., Chen, S.-Y., Chien, M.-H., Zhang, Z.-X., Hsu, W.-H., Wang, X., Zhang, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42402-3 · Cited by 63
Self-citationHassanzadeh‐Barforoushi, A., Sango, X., Johnston, E. L., Haylock, D. N., & Wang, Y. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70132 · Cited by 71
Self-citationDefois, A., Bon, N., Charpentier, A., Georget, M., Gaigeard, N., Blanchard, F., Hamel, A., Waast, D., Armengaud, J., Renoult, O., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01150-z · Cited by 65
Wang, H., Qiao, C., Guan, Q., Wei, M., & Li, Z. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100829 · Cited by 66
A Facile Magnetic Extrusion Method for Preparing Endosome‐Derived Vesicles for Cancer Drug Delivery
Guo, P., Busatto, S., Huang, J., Morad, G., & Moses, M. A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008326 · Cited by 65
Payandeh, Z., Tangruksa, B., Synnergren, J., Heydarkhan‐Hagvall, S., Nordin, J. Z., Andaloussi, S. E., Borén, J., Wiseman, J., Bohlooly‐Y, M., Lindfors, L., et al. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101302 · Cited by 70
Bioengineered nanotechnology for nucleic acid delivery
Zhang, Y., Luo, J., Gui, X., Zheng, Y., Schaar, E., Liu, G., & Shi, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.034 · Cited by 65
Self-citationThe in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
Jiang, X., Zhang, T., & Gao, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114324 · Cited by 61
Extracellular vesicles as next generation immunotherapeutics
Greening, D. W., Xu, R., Ale, A., Hagemeyer, C. E., & Chen, W. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.02.002 · Cited by 61
Extracellular Vesicles for Drug Delivery in Cancer Treatment
Wang, L., Yu, X., Zhou, J., & Su, C. (2023) · Biological Procedures Online · doi:10.1186/s12575-023-00220-3 · Cited by 61
Jayasinghe, M. K., Tan, M., Peng, B., Yang, Y., Sethi, G., Pirisinu, M., & Le, M. T. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.010 · Cited by 62
Manling, W., Wang, M., Jia, H., & Wu, P. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2104404 · Cited by 62
Nguyen, L. T. H., Zhang, J., Rima, X. Y., Wang, X., Kwak, K. J., Okimoto, T., Amann, J. M., Yoon, M. J., Shukuya, T., Chiang, C., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12258 · Cited by 56
Self-citationTherapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer
Avgoulas, D. I., Tasioulis, K. S., Papi, R. M., & Pantazaki, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051439 · Cited by 57
Efficient encapsulation of biocompatible nanoparticles in exosomes for cancer theranostics
Tanziela, T., Shaikh, S. A., Jiang, H., Lu, Z., & Wang, X. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100964 · Cited by 59
Self-citationLiu, B., Kong, Y., Shi, W., Kuss, M. A., Liao, K., Hu, G., Xiao, P., Sankarasubramanian, J., Guda, C., Wang, X., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.022 · Cited by 62
Self-citationExtracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity
You, Y., Tian, Y. P., Guo, R., Shi, J., Kwak, K. J., Tong, Y., Estania, A. P., Hsu, W., Liu, Y., Hu, S., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae883 · Cited by 66
Self-citationNonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
Wang, Y., Zhang, R., Tang, L., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030512 · Cited by 58
Self-citationNanotechnology in coronary heart disease
Guo, J., Wang, H., Li, Y., Zhu, S., Hu, H., & Gu, Z. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.011 · Cited by 58
Liu, X., Wei, Q., Sun, Z., Cui, S., Wan, X., Chu, Z., Zhang, Y., Zhong, W., Lu, L., Shi, L., et al. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230019 · Cited by 56
Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis
Gorshkov, A. N., Purvinsh, L. V., Brodskaia, A. V., & Vasin, A. V. (2022) · Nanomaterials · doi:10.3390/nano12030524 · Cited by 60
Research Progress on Stem Cell Therapies for Articular Cartilage Regeneration
Jiang, S., Tian, G., Li, X., Yang, Z., Wang, F., Tian, Z., Huang, B., Fu, W. E., Zha, K., Sun, Z., et al. (2021) · Stem Cells International · doi:10.1155/2021/8882505 · Cited by 62
Self-citationBiomimetic and cell-based nanocarriers – New strategies for brain tumor targeting
Mendanha, D., de Castro, J. V., Ferreira, H., & Neves, N. M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.047 · Cited by 56
Abesekara, M. S., & Chau, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.972790 · Cited by 56
Extracellular Vesicles as Therapeutic Tools for the Treatment of Chronic Wounds
Bray, E. R., Oropallo, A., Grande, D. A., Kirsner, R. S., & Badiavas, E. V. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101543 · Cited by 56
Therapeutic potential of extracellular vesicle‐associated long noncoding RNA
Born, L. J., Harmon, J. W., & Jay, S. M. (2020) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10172 · Cited by 53
Mammalian Cells Exocytose Alkylated Gold Nanoparticles via Extracellular Vesicles
Ho, L. W. C., Chan, C. K. W., Han, R., Lau, Y. F. Y., Li, H., Ho, Y., Zhuang, X., & Choi, C. H. J. (2022) · ACS Nano · doi:10.1021/acsnano.1c07418 · Cited by 56
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
Han, G., Noh, D., Lee, H., Lee, S., Kim, S., Yoon, H. Y., & Hyeon, L. S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114973 · Cited by 53
Zickler, A. M., Liang, X., Gupta, D., Mamand, D. R., Luca, M. D., Corso, G., Errichelli, L., Hean, J., Sen, T., Elsharkasy, O. M., et al. (2024) · Advanced Science · doi:10.1002/advs.202407619 · Cited by 55
A High‐Throughput Nanofluidic Device for Exosome Nanoporation to Develop Cargo Delivery Vehicles
Hao, R., Yu, Z., Du, J., Hu, S., Yuan, C., Guo, H., Zhang, Y., & Yang, H. (2021) · Small · doi:10.1002/smll.202102150 · Cited by 52
Wang, X., Hu, S., Zhu, D., Li, J., Cheng, K., & Liu, G. (2023) · Nano Research · doi:10.1007/s12274-023-5374-3 · Cited by 54
Self-citationExosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer
Patel, G., Agnihotri, T. G., Gitte, M., Shinde, T., Gomte, S. S., Goswami, R., & Jain, A. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00810-z · Cited by 53
Extracellular Vesicles: Recent Advances and Perspectives
Ragni, E. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36405 · Cited by 59
High Throughput and Highly Controllable Methods for In Vitro Intracellular Delivery
Brooks, J. R., Minnick, G., Mukherjee, P., Jaberi, A., Chang, L., Espinosa, H. D., & Yang, R. (2020) · Small · doi:10.1002/smll.202004917 · Cited by 51
Aptamer–Exosomes for Tumor Theranostics
Yi, K., Rong, Y., Huang, L., Tang, X., Zhang, Q., Wang, W., Wu, J., & Wang, F. (2021) · ACS Sensors · doi:10.1021/acssensors.0c02237 · Cited by 50
Non-invasive PTEN mRNA brain delivery effectively mitigates growth of orthotopic glioblastoma
Liu, Y., Zhang, D., An, Y., Sun, Y., Li, J., Zheng, M., Zou, Y., & Shi, B. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101790 · Cited by 52
Wang, Q., Liu, K., Cao, X., Rong, W., Shi, W., Yu, Q., Deng, W., Yu, J., & Xu, X. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10646 · Cited by 51
Self-citationLight‐induced high‐efficient cellular production of immune functional extracellular vesicles
Ruan, S., Erwin, N., & He, M. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12194 · Cited by 51
Lu, X., Fan, S., Cao, M., Liu, D., Xuan, K., & Liu, A. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-024-00699-2 · Cited by 56
Extracellular vesicles for renal therapeutics: State of the art and future perspective
Tang, T., Wang, B., Lv, L., Dong, Z., & Liu, B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.049 · Cited by 51
Li, M., Jiang, P., Wei, S., Wang, J., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113312 · Cited by 52
Extracellular vesicles as carriers of mRNA: Opportunities and challenges in diagnosis and treatment
Kirian, R. D., Steinman, D., Jewell, C. M., & Zierden, H. C. (2024) · Theranostics · doi:10.7150/thno.93115 · Cited by 49
Emerging prospects of extracellular vesicles for brain disease theranostics
Wang, R., Wang, X., Zhang, Y., Zhao, H., Cui, J., Li, J., & Di, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.024 · Cited by 48
Self-citation
Metadata
- Authors
- Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., Malkoc, V., Chiang, C., Deng, W., Chen, Y., Fu, Y., Kwak, K. J., Fan, Y., Kang, C., Yin, C., Rhee, J., Bertani, P., Otero, J., Lu, W., Yun, K., Lee, A. S., Jiang, W., Teng, L., Kim, B. Y. S., & Lee, L. J.
- Affiliations
- The Ohio State University (US)
- Jilin University (CN)
- The University of Texas Southwestern Medical Center (US)
- Jinan University (CN)
- Mayo Clinic (US)
- Peking University (CN)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Houston Methodist Research Institute (US)
- Shenzhen Bay Laboratory (CN)
- Corresponding author
- Teng, Lesheng
- Kim, Betty Y. S.
- Lee, L. James
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2019-12-16
- Volume
- 4
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC7080209
- OpenAlex
- W2995128645
- Cited by
- 744
- References
- 49
- Citations by year
- 2026: 81 · 2025: 125 · 2024: 135 · 2023: 128 · 2022: 117 · 2021: 101 · 2020: 56
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA241070)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS104315)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, mRNA delivery, electroporation, exosome production, targeting peptides, tumor suppression, nucleic acid carriers, exosome secretion, brain tumors
- MeSH terms
- Animals, Brain Neoplasms, Cells, Cultured, Disease Models, Animal, Glioma, Humans, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Drug Delivery Systems, Electroporation, MicroRNAs, Nanotechnology, Exosomes, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
